Quantifying the Association between Campylobacter Infection and Guillain-Barré Syndrome: A Systematic Review

Guillain-Barré Syndrome (GBS) is a neurologic disease that causes ascending paralysis and is triggered by a preceding bacterial or viral infection. Several studies have shown that patients with GBS have a recent history of infection due to Campylobacter jejuni. A literature review of published studi...

Full description

Saved in:
Bibliographic Details
Published in:Journal of health, population and nutrition Vol. 28; no. 6; pp. 545 - 552
Main Authors: Poropatich, Kate O., Walker, Christa L. Fischer, Black, Robert E.
Format: Journal Article
Language:English
Published: Bangladesh ICDDR,B: Centre for Health and Population Research 01.12.2010
BioMed Central Ltd
Springer Nature B.V
International Centre for Diarrhoeal Disease Research, Bangladesh
Subjects:
Antibodies
Bacterial infection
Campylobacter
Campylobacter infections
Campylobacter Infections - complications
Campylobacter jejuni
Care and treatment
Case control studies
Case studies
Cohort studies
Complications and side effects
Conjunction
Diagnosis
Guillain Barre syndrome
Guillain-Barre Syndrome - epidemiology
Guillain-Barre Syndrome - etiology
Humans
Incidence
Infection
Infections
Literature reviews
Neurological disorders
Neurology
Original Papers
Paralysis
Patients
Peripheral nervous system diseases
Personal health
Systematic review
Viral infections
United States
ISSN:1606-0997, 2072-1315
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Guillain-Barré Syndrome (GBS) is a neurologic disease that causes ascending paralysis and is triggered by a preceding bacterial or viral infection. Several studies have shown that patients with GBS have a recent history of infection due to Campylobacter jejuni. A literature review of published studies that reported rates of Campylobacter infection before or in conjunction with GBS was done. These reported data were used for calculating the proportion of GBS cases who tested positive for Campylobacter compared to the control population and the incidence of GBS among patients infected with Campylobacter. Results of the analysis suggest that 31% of 2,502 GBS cases included in these papers are attributable to Campylobacter infection.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
ISSN:1606-0997
2072-1315
DOI:10.3329/jhpn.v28i6.6602